The CDC did not break out most data for county or region, but for New York State in 2023 ... which tests people like those ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

We need to diversify our HIV workforce with new roles that align with the health and well ... and nurse scientist with ...

The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels.

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

In 2023, the U.S. reported over a million more sexually transmitted infections than in 2004, according to the CDC.Thousands ...

A new proven protocol in which doxycycline is used to prevent sexually transmitted infections, called doxyPEP, has been an ...

Although sexually transmitted infections are still at an epidemic level in the US, scientists at the US Centers for Disease ...

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained ...

and these new data continue to reinforce the efficacy and safety of Dovato, a two-drug regimen. “The findings from the DOLCE ...